Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01501838

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Lung Diseases Pulmonary Arterial Hypertension Respiratory Tract Diseases

Age range

17 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Italiano de Buenos Aires

Buenos Aires, 1181, Argentina

Location status: Recruiting

Location contact

Ignacio M Bluro, MD

CONTACT

[email protected]

+541149590200 ext. 5303

Ignacio M Bluro, MD

PRINCIPAL_INVESTIGATOR

About this study

The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension type I. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:
  • Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) >15 mmHg and pulmonary vascular resistance (PVR) >2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
  • Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
  • Aged ≥18 years at the index date.
  • Exclusion Criteria History of lung transplantation surgery previously the baseline period

Treatment and study plan

Primary outcomes

  1. Pulmonary Hypertension prevalence

    Time frame: 1 year

    Pulmonary Hypertension prevalence in our community.

  2. Pulmonary Hypertension incidence

    Time frame: 1 year

    Pulmonary Hypertension incidence in our community

Secondary outcomes

  1. Mortality rate

    Time frame: 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Ignacio M Bluro, MD

CONTACT

[email protected]

+541149590200 ext. 5303

Sponsors and collaborators

Lead sponsor

Hospital Italiano de Buenos Aires

Other

Registry information

Acronym: PH-HIBA

Important dates

Study start
2017
Primary completion
2030
Study completion
2031
First posted
Dec 29, 2011
Registry last updated
Aug 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.